By integrating Food-as-Medicine, gut microbiome science, and clinical coaching , Digbi helps members lose more weight, regain less, and reduce the total cost of carewhether they use a GLP-1 or not
The body composition implications of that trade-off, and what testosterone can do to address them, are examined in detail in the combination strategy section that follows
Who is most at risk Not everyone on retatrutide will develop skin sensitivity
Stay updated on stories like this Get news delivered to your inbox One in eight American adults currently takes a GLP-1 drug such as Ozempic or Wegovy either to lose weight or treat a chronic condition a figure that has risen significantly since 2023, according to a November 2025 Kaiser Family Foundation Health Tracking Poll
Jenifer comparti los retos y estrategias de la terapia nutricional en la prctica clnica para pacientes con EII